These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7024638)

  • 1. EMIT cannabinoid assay: confirmation by RIA and GC/MS.
    O'Connor JE; Rejent TA
    J Anal Toxicol; 1981; 5(4):168-73. PubMed ID: 7024638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A research note: the outcome of GC/MS/MS confirmation of hair assays on 93 cannabinoid (+) cases.
    Mieczkowski T
    Forensic Sci Int; 1995 Jan; 70(1-3):83-91. PubMed ID: 7860039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of EMIT and RIA high volume test procedures for THC metabolites in urine utilizing GC/MS confirmation.
    Abercrombie ML; Jewell JS
    J Anal Toxicol; 1986; 10(5):178-80. PubMed ID: 3022068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.
    Verebey K; Mulé SJ; Alrazi J; Lehrer M
    J Anal Toxicol; 1986; 10(2):79-80. PubMed ID: 3517489
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method comparison of EMIT 700 and EMIT II with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Anal Toxicol; 1994; 18(2):110-7. PubMed ID: 8207931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method comparison of EMIT II and online with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Forensic Sci; 1993 Nov; 38(6):1326-41. PubMed ID: 8263477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens.
    Schwartz RH; Bogema S; Thorne MM
    Pediatr Emerg Care; 1990 Jun; 6(2):147-9. PubMed ID: 2196539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marijuana testing--how good is it?
    Moyer TP; Palmen MA; Johnson P; Charlson JR; Ellefson PJ
    Mayo Clin Proc; 1987 May; 62(5):413-7. PubMed ID: 3553756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitation of cannabinoid immunoassays? A reexamination of the EMIT 20-ng/mL assay.
    Haver VM; Romson JL; Sadrzadeh SM
    J Anal Toxicol; 1991; 15(2):98-100. PubMed ID: 1646909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cannabinoid analysis: comparison of four immunoassays with gas chromatography-mass spectrometry.
    Altunkaya D; Clatworthy AJ; Smith RN; Start IJ
    Forensic Sci Int; 1991; 50(1):15-22. PubMed ID: 1937304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.